Anew Health Ltd. (AVG) plans to raise $9 million through an initial public offering (IPO) scheduled for November 21, 2025. The company aims to issue 1,800,000 shares priced between $4.00 and $6.00 each, according to information reported by IPO Scoop. This move is set against a backdrop of positive financial performance, with Anew Health generating $40.02 million in revenue and $5.54 million in net income for the fiscal year ending March 31, 2025.
Established in 2007 and headquartered in Hong Kong, Anew Health specializes in pain management and health services. The company operates under the brand name ANKH, which stands for “A New Key to Health.” This reflects its mission to not only alleviate physical pain but also promote overall well-being and vitality.
Company Overview and Offerings
Anew Health’s portfolio includes a variety of non-surgical and non-invasive treatments. Its services focus on pain management, functional enhancement therapies, and health products such as dietary supplements. The company employs an approach referred to as RDS+ (Restore, Detox, and Strengthen) that integrates the principles of Traditional Chinese Medicine (TCM) with advanced energy-based therapies.
The RDS+ approach aims to restore the healthy flow of vital energy, or Qi, which TCM suggests is essential for alleviating pain and promoting health. Anew Health’s treatments utilize various modalities, including laser therapy, bioelectrical current, electromagnetic treatment, radiofrequency, and ultrasound, to address both acute and chronic pain conditions.
Anew Health Ltd. has approximately 245 employees and is located at Unit 2301-05, 23/F, Tower 5, The Gateway Harbour City, 15 Canton Road, Tsim Sha Tsui, Kowloon, Hong Kong. The company can be contacted at +852 3845 5012 or through its website at https://www.ankh.com.hk/.
IPO Underwriting and Future Prospects
The IPO is being underwritten by D. Boral Capital, previously known as EF Hutton. The anticipated capital from this offering will support further development and expansion of Anew Health’s innovative treatment options, which have garnered attention in the health services sector.
With a market capitalization of $259 million, Anew Health is poised to leverage its established brand and proven business model as it enters the public market. The company’s commitment to integrating traditional healing practices with modern technology positions it uniquely in the rapidly evolving healthcare landscape.
As Anew Health prepares for its IPO, the company will continue to focus on improving health outcomes for its clients while expanding its reach within the industry. The upcoming offering marks a significant milestone in Anew Health’s journey, reflecting its growth and commitment to enhancing the quality of life through holistic health solutions.
